SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,482,000 | -70.2% | 79,700 | -63.6% | 0.02% | -72.6% |
| Q1 2021 | $4,980,000 | -12.0% | 218,800 | -16.0% | 0.07% | -19.8% |
| Q4 2020 | $5,658,000 | +758.6% | 260,600 | +297.6% | 0.09% | +550.0% |
| Q3 2020 | $659,000 | +29.5% | 65,542 | 0.0% | 0.01% | +16.7% |
| Q2 2020 | $509,000 | -82.8% | 65,542 | -77.3% | 0.01% | -87.9% |
| Q1 2020 | $2,951,000 | -4.5% | 289,306 | +3.0% | 0.10% | +20.7% |
| Q4 2019 | $3,090,000 | +21.6% | 280,934 | +0.5% | 0.08% | -1.2% |
| Q3 2019 | $2,541,000 | -18.5% | 279,577 | +2.1% | 0.08% | -15.3% |
| Q2 2019 | $3,117,000 | +13.6% | 273,906 | +13.6% | 0.10% | -4.9% |
| Q1 2019 | $2,745,000 | -7.8% | 241,027 | -27.0% | 0.10% | -18.9% |
| Q4 2018 | $2,978,000 | -44.6% | 330,210 | -7.8% | 0.13% | -23.0% |
| Q3 2018 | $5,374,000 | – | 358,278 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |